Literature DB >> 18784604

Immune reconstitution associated with progressive multifocal leukoencephalopathy in human immunodeficiency virus: a case discussion and review of the literature.

Jennifer Travis1, Anoop Varma, Daniel duPlessis, Ian Turnbull, F Javier Vilar.   

Abstract

OBJECTIVES: To report the neuropathological findings of a patient with immune reconstitution syndrome associated with progressive multifocal leukoencephalopathy (PML) in human immunodeficiency virus (HIV) and to review the literature.
METHODS: A 38-year-old man was presented with a rapidly evolving brainstem syndrome. Serology for HIV was positive with an initial CD4 count of 130 cells/mL3. Magnetic resonance imaging showed widespread high signal changes within the brainstem bilaterally, the cerebellum, inferior cerebellar peduncle, and the frontal lobe on the right. Opportunistic infections were excluded from blood and cerebrospinal fluid samples. Despite treatment with antiretrovirals, he continued to deteriorate neurologically, and a repeat magnetic resonance imaging scan showed progression of his lesions. Cortical wedge frontal lobe brain biopsy showed features characteristic of PML, but was associated with an exaggerated inflammatory response. Polymerase chain reaction analysis of the specimen demonstrated the presence of JC virus (JCV) DNA, confirming the pathologic impression of PML.
RESULTS: The patient made a rapid (within 24 hours) improvement with pulsed methylprednisolone and has maintained a clinical response 7 months later. These features clinically, radiologically, and histopathologically suggest an added component in the form of immune reconstitution syndrome to PML.
CONCLUSION: This report highlights the need to carefully evaluate the clinical syndrome in patients with HIV-associated leukoencephalopathy. It also substantiates the role of corticosteroids in carefully considered cases of HIV with leukoencephalopathy secondary to immune reconstitution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18784604     DOI: 10.1097/NRL.0b013e31816e2f13

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  7 in total

Review 1.  The immune reconstitution inflammatory syndrome related to HIV co-infections: a review.

Authors:  D Huis in 't Veld; H-Y Sun; C-C Hung; R Colebunders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-02       Impact factor: 3.267

2.  Putative episodes of T-cell-mediated rejection in patients with sustained BK viruria but no viremia.

Authors:  Kosuke Masutani; Ron Shapiro; Amit Basu; Henkie Tan; Toshiharu Ninomiya; Parmjeet Randhawa
Journal:  Transplantation       Date:  2012-07-15       Impact factor: 4.939

3.  Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis.

Authors:  Boleslaw Lach; Barbara Connolly; Christian Wüthrich; Igor J Koralnik
Journal:  Neuropathology       Date:  2013-05-20       Impact factor: 1.906

4.  Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system.

Authors:  Dennis W Raisch; John A Rafi; Cheng Chen; Charles L Bennett
Journal:  Expert Opin Drug Saf       Date:  2016-06-20       Impact factor: 4.250

5.  Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a man with AIDS.

Authors:  Katie Yoganathan; David Brown; Kathir Yoganathan
Journal:  Int J Gen Med       Date:  2012-04-13

Review 6.  Immune Reconstitution Inflammatory Syndrome Unmasking or Worsening AIDS-Related Progressive Multifocal Leukoencephalopathy: A Literature Review.

Authors:  Anna Fournier; Guillaume Martin-Blondel; Emmanuèle Lechapt-Zalcman; Julia Dina; Apolline Kazemi; Renaud Verdon; Emmanuel Mortier; Arnaud de La Blanchardière
Journal:  Front Immunol       Date:  2017-05-23       Impact factor: 7.561

Review 7.  SETDB1 in cancer: overexpression and its therapeutic implications.

Authors:  Vanessa J Lazaro-Camp; Kiarash Salari; Xiangbing Meng; Shujie Yang
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.